Featured post

A Highly Pathogenic #Avian #H7N9 #Influenza Virus Isolated from A #Human Is Lethal in Some #Ferrets Infected via #Respiratory #Droplets (Cell Host Microbe, abstract)

Title : A Highly Pathogenic #Avian #H7N9 #Influenza Virus Isolated from A #Human Is Lethal in Some #Ferrets Infected via #Respiratory #Drop...

10 Nov 2012

Research Articles Abstracts – November 10 2012 Issue

[Source: AMEDEO, homepage: (LINK).]

Research Articles Abstracts – November 10 2012 Issue


This week’s abstracts:

  1. Xu J, Yang D, Huang D, Xu J, et al.
    • Protection of guinea pigs by vaccination with a recombinant swinepox virus co-expressing HA1 genes of swine H1N1 and H3N2 influenza viruses.
  2. El Moussi A, Ledesma J, Ben Hadj Kacem MA, Pozo F, et al.
    • Haemagglutinin D222G mutation found in a fatal case of pandemic (H1N1) flu in Tunisia.
  3. Fujisaki S, Takashita E, Yokoyama M, Taniwaki T, et al.
    • A single E105K mutation far from the active site of influenza B virus neuraminidase contributes to reduced susceptibility to multiple neuraminidase-inhibitor drugs.
      • Biochem Biophys Res Commun. 2012 Nov 3. pii: S0006-291X(12)02087. 
      • PubMed
      • Related Articles
      • Abstract available
  4. Tran AT, Cortens JP, Du Q, Wilkins JA, et al.
    • Influenza Virus Induces Apoptosis via BAD-mediated Mitochondria Dysregulation.
  5. Banyai K, Kovacs E, Toth AG, Biksi I, et al.
    • Genome Sequence of a Monoreassortant H1N1 Swine Influenza Virus Isolated from a Pig in Hungary.
  6. Watanabe T, Imai M, Watanabe S, Shinya K, et al.
    • Characterization in vitro and in vivo of pandemic (H1N1) 2009 influenza viruses isolated from patients.
  7. Kulkarni PS, Manjunath K, Agarkhedkar S.
    • Safety and immunogenicity of an adjuvanted whole virion, inactivated A (H1N1) 2009 influenza vaccine in young and elderly adults, and children.
  8. Schwarz TF, Schmoele-Thoma B.
    • Assessment of functional antibacterial opsonophagocytic antibodies elicited by 13-valent pneumococcal conjugate vaccine administered concomitantly with trivalent influenza vaccine in a randomized clinical trial in adults aged >/=65 years.
  9. Shinjo SK, de Moraes JC, Levy-Neto M, Aikawa NE, et al.
    • Pandemic unadjuvanted influenza A (H1N1) vaccine in dermatomyositis and polymyositis: Immunogenicity independent of therapy and no harmful effect in disease.
  10. Gorman JR, Brewer NT, Wang JB, Chambers CD, et al.
    • Theory-based predictors of influenza vaccination among pregnant women.
  11. Gong M, Zhou J, Yang C, Deng Y, et al.
    • Insect cell-expressed hemagglutinin with CpG oligodeoxynucleotides plus alum as an adjuvant is a potential pandemic influenza vaccine candidate.
  12. Landelle C, Vanhems P, Saadatian-Elahi M, Voirin N, et al.
    • Influenza vaccination coverage among patients and healthcare workers in a university hospital during the 2006-2007 influenza season.
  13. Plant EP, Liu TM, Xie H, Ye Z, et al.
    • Mutations to A/Puerto Rico/8/34 PB1 gene improves seasonal reassortant influenza A virus growth kinetics.
  14. Pandolfi E, Carloni E, Marino MG, Ciofi degli Atti ML, et al.
    • Immunization coverage and timeliness of vaccination in Italian children with chronic diseases.
  15. Beato MS, Mancin M, Yang J, Buratin A, et al.
    • Antigenic characterization of recent H5N1 highly pathogenic avian influenza viruses circulating in Egyptian poultry.
  16. Mansbach JM, Piedra PA, Stevenson MD, Sullivan AF, et al.
    • Prospective multicenter study of children with bronchiolitis requiring mechanical ventilation.
  17. Perwitasari O, Yan X, Johnson S, White C, et al.
    • Targeting the Organic Anion Transporter-3 (OAT3) with Probenecid as a Novel Anti-Influenza A Virus Strategy.